Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 2Glioblastoma 2Squamous Cell Carcinoma of Head and Neck 1Head and Neck Neoplasms 1Glioma 1Advanced Malignant Solid Neoplasm 1Advanced Malignancies 1

Interventions

Interviews as Topic 3Educational Status 3Specimen Handling 2Palliative Care 2Methods 2Early Intervention, Educational 2veliparib 1spartalizumab 1siltuximab 1pamiparib 1dinaciclib 1cabozantinib 1Pharmacogenomic Variants 1Patient Comfort 1Paclitaxel 1Nutrition Assessment 1Mindfulness-Based Stress Reduction 1Mindfulness 1Magnetic Resonance Spectroscopy 1Health Promotion 1Diet Therapy 1Biopsy 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignant Solid Neoplasm × pamiparib × 1 year × Clear all
NCT05038839 2026-05-12

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Completed
44 enrolled
Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡